New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 9, 2014
09:19 EDTAKRXAkorn to acquire VersaPharm for $440M in cash
Akorn announced that it has entered into a definitive agreement to acquire VPI Holdings Corp., the parent company of VersaPharm Incorporated, for $440M in cash. This acquisition is expected to add $90M-$100M in annual revenues and 10c-12c in EPS, excluding new pipeline launches, deal amortization and acquisition-related expenses. Akorn intends to fund the transaction through approximately $445M in term loan borrowings. Fully committed financing for the transaction has been provided by JPMorgan Chase Bank, N.A. The acquisition will be subject to customary conditions, including termination of the waiting period under the provisions of the Hart-Scott-Rodino Antitrust Improvement Act of 1976, as amended. Pending the satisfaction of such customary conditions, Akorn anticipates closing the transaction in 3Q14.
News For AKRX From The Last 14 Days
Check below for free stories on AKRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 19, 2014
14:18 EDTAKRXAkorn competition settlement over VersaPharm deal approved by FTC
Subscribe for More Information
September 15, 2014
07:10 EDTAKRXAkorn potential KUDCo deal makes strategic sense, says Piper Jaffray
Subscribe for More Information
September 12, 2014
09:00 EDTAKRXNeedham skeptical of potential Akorn deal for Kremers
Subscribe for More Information
September 11, 2014
12:56 EDTAKRXAkorn exploring 'inversion' deal for Belgian drugmaker unit, Reuters says
Subscribe for More Information
12:55 EDTAKRXAkorn pursuing potential inversion deal for UCB unit, Reuters says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use